Pfizer falls from ranks of top 10 US advertisers
Tougher stance by FDA slows industry spending on marketing in 1st half
Pfizer Inc. , the world's largest drug maker, tumbled from the ranks of the nation's top 10 advertisers as overall pharmaceutical industry spending on advertising slowed during the first half of the year, according to an ad-monitoring research firm. (Full article: 800 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
